9084
J. Am. Chem. Soc. 1998, 120, 9084-9085
Scheme 1
Asymmetric Total Synthesis of Callystatin A:
Asymmetric Aldol Additions with Titanium Enolates
of Acyloxazolidinethiones
Michael T. Crimmins* and Bryan W. King
Venable and Kenan Laboratories of Chemistry
The UniVersity of North Carolina at Chapel Hill
Chapel Hill, North Carolina 27599-3290
ReceiVed May 20, 1998
A number of highly cytotoxic polyketides, including the
anguinomycins,1 leptofuranins,2 leptomycin,3 and kazusamycin,4
having similar gross chemical structures have been isolated from
Streptomyces strains. Recently, a structurally related polyketide,
callystatin A 1, was isolated from the marine sponge, Callyspongia
truncata, in the Nagasaki Prefecture.5 Callystatin A shows
remarkable in vitro cytotoxicity (IC50 ) 0.01 ng/mL) against KB
cells. The relative and absolute stereostructure of callystatin A
was established by a combination of spectroscopic methods and
chemical synthesis.5-7 The limited quantities of callystatin A
available from natural sources, as well as the possibility for
carrying out syntheses and structure elucidation of the related
antitumor antibiotics, prompted us to pursue a total synthesis of
callystatin A.8 Here we disclose the asymmetric total synthesis
of (-)-callystatin A exploiting our recently developed asymmetric
aldol protocol with chlorotitanium enolates of acyl oxazolidi-
nethiones.9
Scheme 2
Strategically, E-selective olefination10 of aldehyde 2 (Scheme
1) with the phosphorane derived from tributylphosphonium salt
3 appeared to offer the most convergent assembly of callystatin
A. Aldehyde 2 representing C1 to C12 would be constructed
from a similar olefination between the masked pyranone aldehyde
4 (Scheme 2) and phosphonium salt 5 (Scheme 3). The C13 to
C22 propionate fragment 3 was to be constructed through
consecutive asymmetric aldol additions9 employing acyl oxazo-
lidinethione 6 (Scheme 4).
Scheme 3
The synthesis of aldehyde 4 began with S-glycidol 7 as
illustrated in Scheme 2. Protection of S-glycidol as its TBDPS
ether followed by copper-catalyzed epoxide opening with vinyl-
magnesium bromide provided the alcohol 8 in 85% overall yield.
Conversion of the secondary alcohol to the isopropoxy propenyl
ether provided a mixed acetal which was exposed to the Grubbs
catalyst11 to effect ring-closing metathesis to dihydropyran 9 (71%
overall). Removal of the TBPDS protecting group with n-Bu4-
* To whom correspondence may be addressed. E-mail: mtc@
net.chem.unc.edu.
(1) Hayakawa, Y.; Adachi, K.; Komeshima, N. J. Antibiot. 1987, 40, 1349-
1352. Hayakawa, Y.; Sohda, K.; Shin-ya, K.; Hidaka, T.; Seto, H. J. Antibiot.
1995, 48, 954-961.
(2) Hayakawa, Y.; Sohda, K.; Seto, H. J. Antibiot. 1996, 49, 980-984.
(3) Hammamoto, T.; Seto, H.; Beppu, T. J. Antibiot. 1983, 36, 646-650.
Hurley, T. R.; Bunge, R. H.; Willer, N. E.; Hokanson, G. C.; French, J. C. J.
Antibiot. 1986, 39, 1651-1656. Schaumberg, J. P.; Hokanson, G. C.; French,
J. C. J. Chem. Soc., Chem. Commun. 1984, 1450-1452.
(4) Komiyama, K.; Okada, K.; Oka, H.; Tomisaka, S.; Miyano, T.;
Funayama, S.; Umezawa, I. J. Antibiot. 1985, 38, 220-223.
(5) Kobayashi, M.; Higuchi, K.; Murakami, N.; Tajima, H.; Aoki, S.
Tetrahedron Lett. 1997, 38, 2859-2862.
NF and Swern oxidation of the resultant alcohol provided a 90%
yield of the requisite aldehyde 4 (C1 to C6 fragment).
The C7 to C12 phosphonium salt 5, required for the olefination
reaction with aldehyde 4, was constructed as shown in Scheme
3. Oxidative cleavage of the known12 alkene 10 followed by in
situ reduction of the aldehyde and subsequent protection of the
primary alcohol provided 80% of the pivalate 11. Dibal-H
reduction of the pivalate ester followed by Swern oxidation of
the primary alcohol gave the aldehyde 12 in 88% overall yield.
The C8-C9 Z-olefin was installed by utilizing Still’s protocol
(6) Murakami, N.; Wang, W.; Aoki, M.; Tsutsui, Y.; Sugimoto, M.;
Kobayashi, M. Tetrahedron Lett. 1997, 38, 5533-5536.
(7) Murakami, N.; Wang, W.; Aoki, M.; Tsutsui, Y.; Higuchi, K.; Aoki,
S.; Kobayashi, M. Tetrahedron Lett. 1998, 39, 2349-2352.
(8) During the preparation of this manuscript, the first total synthesis of
(-)-callystatin A was reported (see ref 7).
(9) Crimmins, M. T.; King, B. W.; Tabet, E. A. J. Am. Chem. Soc. 1997,
119, 7883-7884.
(10) Tamura, R.; Saegusa, K.; Kakihana, M.; Oda, D. J. Org. Chem. 1988,
53, 2723-2728.
(11) Grubbs, R. H.; Miller, S. J., Fu, G. C. Acc. Chem. Res. 1995, 28,
446-452.
(12) Overman, L. E.; Robinson, L. A.; Zablocki, J. J. Am. Chem. Soc. 1992,
114, 368-369.
S0002-7863(98)01750-8 CCC: $15.00 © 1998 American Chemical Society
Published on Web 08/19/1998